会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • INTERLOCKING COMPONENT ASSEMBLY SYSTEM
    • 互锁组件组装系统
    • WO2007020484A3
    • 2007-04-19
    • PCT/IB2004004476
    • 2004-07-27
    • THAI UNIVERSAL OFFICE PRODUCTSBAKER KEVIN
    • BAKER KEVIN
    • F16B12/38A47B47/02A47B47/05A47B67/04F16B12/02
    • F16B12/38A47B47/0075A47B47/02A47B47/05
    • An interlocking component assembly is made of a plurality of frame components and a plurality of panels. One panel is formed integrally with a respective frame to form a frame and panel component. A channel formed along the entire periphery of each of the frame components enables each of the frame and panel components to be interconnected. During assembly the channel of one frame component is inserted within a channel of another frame component to lock the components together along the length thereof. A plurality of locking tabs are disposed within the channel of each of the plurality of frame components. A plurality of apertures are also disposed within the channel of each of the plurality of frame components, wherein when the channel of a frame component is inserted within the channel of another frame component at least one locking tab is received within a corresponding aperture. This process is repeated until a three-dimensional unit is formed.
    • 互锁部件组件由多个框架部件和多个面板构成。 一个面板与相应的框架一体地形成以形成框架和面板部件。 沿着每个框架部件的整个周边形成的通道使得框架和面板部件中的每一个能够相互连接。 在组装期间,一个框架部件的通道被插入另一个框架部件的通道中,以沿着其长度将部件锁定在一起。 多个锁定突出部设置在多个框架部件的每个的通道内。 多个孔也设置在多个框架部件的每一个的通道内,其中当框架部件的通道插入到另一个框架部件的通道内时,至少一个锁定突片被接收在相应的孔内。 重复该过程直到形成三维单元。
    • 6. 发明申请
    • FURTHER PRO POLYPEPTIDES AND SEQUENCES THEREOF
    • 其他多肽及其序列
    • WO0012708A3
    • 2001-10-04
    • PCT/US9920111
    • 1999-09-01
    • GENENTECH INCBAKER KEVINGODDARD AUDREYGURNEY AUSTIN LSMITH VICTORIAWATANABE COLIN KWOOD WILLIAM I
    • BAKER KEVINGODDARD AUDREYGURNEY AUSTIN LSMITH VICTORIAWATANABE COLIN KWOOD WILLIAM I
    • C07K14/705C12N15/12C07K16/28C12N5/10C12N15/62C12Q1/68
    • C07K14/705C07K2319/00
    • Membrane-bound proteins and receptor molecules have various industrial applications, including as pharmaceutical and diagnostic agents. Receptor immunoadhesins, for instance, can be employed as therapeutic agents to block receptor-ligand interactions. The membrane-bound proteins can also be employed for screening of potential peptide or small molecule inhibitors of the relevant receptor/ligand interaction. Efforts are being undertaken by both industry and academia to identify new, native receptor or membrane-bound proteins. Many efforts are focused on the screening of mammalian recombinant DNA libraries to identifiy the coding sequences for novel receptor or membrane-bound proteins. The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
    • 膜结合蛋白和受体分子具有各种工业应用,包括作为药物和诊断剂。 例如,受体免疫粘附素可以用作阻断受体 - 配体相互作用的治疗剂。 膜结合蛋白也可用于筛选相关受体/配体相互作用的潜在肽或小分子抑制剂。 工业界和学术界正在努力确定新的天然受体或膜结合蛋白。 许多努力集中在筛选哺乳动物重组DNA文库以鉴定新受体或膜结合蛋白的编码序列。 本发明涉及新型多肽和编码那些多肽的核酸分子。 本文还提供了包含那些核酸序列的载体和宿主细胞,包含与异源多肽序列融合的本发明的多肽的嵌合多肽分子,与本发明的多肽结合的抗体以及本发明的多肽的制备方法 发明。